Ignite Creation Date:
2024-05-05 @ 10:36 PM
Last Modification Date:
2024-10-26 @ 10:21 AM
Study NCT ID:
NCT01147016
Status:
TERMINATED
Last Update Posted:
2023-04-27
First Post:
2010-06-17
Brief Title:
Targeted T Cells After Neoadjuvant Chemotherapy in Treating Women With Stage II or III Breast Cancer Undergoing Surgery
Sponsor:
Barbara Ann Karmanos Cancer Institute
Organization:
Barbara Ann Karmanos Cancer Institute
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Breast Cancer |
Keywords:
| Name | View |
|---|---|
| triple-negative breast cancer | View |
| estrogen receptor-negative breast cancer | View |
| HER2-negative breast cancer | View |
| male breast cancer | View |
| progesterone receptor-negative breast cancer | View |
| recurrent breast cancer | View |
| stage IIA breast cancer | View |
| stage IIB breast cancer | View |
| stage IIIA breast cancer | View |
| stage IIIB breast cancer | View |